{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:10:39Z","timestamp":1790403039087,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"Medical Research Council of South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jsbmb.2023.106440","type":"journal-article","created":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T18:48:54Z","timestamp":1701542934000},"page":"106440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Progestins and breast cancer hallmarks: The role of the ERK1\/2 and JNK pathways in estrogen receptor positive breast cancer cells"],"prefix":"10.1016","volume":"237","author":[{"given":"Renate","family":"Louw-du Toit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishkah","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donita","family":"Africander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2023.106440_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.coemr.2020.10.001","article-title":"Progestins in menopausal hormone therapy and breast cancer risk: the debate continues","author":"Africander","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.jsbmb.2023.106440_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/er.2017-00103","article-title":"Hormonal contraception and HIV-1 acquisition: biological mechanisms","volume":"39","author":"Hapgood","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2023.106440_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2023.106440_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women\u2019s health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jsbmb.2023.106440_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2023.106440_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: Results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2023.106440_bib7","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/0008-5472.CAN-11-4064","article-title":"Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20\u201344 years of age","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jsbmb.2023.106440_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1055-9965.EPI-13-0944","article-title":"Oral contraceptives and breast cancer risk overall and by molecular subtype among young women","volume":"23","author":"Beaber","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jsbmb.2023.106440_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.bjc.6600691","article-title":"Hormonal content and potency of oral contraceptives and breast cancer risk among young women","volume":"88","author":"Althuis","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2023.106440_bib11","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f4rch","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2023.106440_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/0284186X.2015.1062538","article-title":"Levonorgestrel-releasing intrauterine system and the risk of breast cancer: a nationwide cohort study","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol. (Madr. )."},{"key":"10.1016\/j.jsbmb.2023.106440_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.maturitas.2019.04.205","article-title":"Effects of drospirenone and norethisterone acetate combined with estradiol on mammographic density and proliferation of breast epithelial cells-A prospective randomized trial","volume":"126","author":"Hirschberg","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2023.106440_bib14","doi-asserted-by":"crossref","first-page":"821.e1","DOI":"10.1016\/j.ajog.2021.12.022","article-title":"Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses\u2019 Health Study II: a prospective cohort study","volume":"226","author":"Burchardt","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2017.11.010","article-title":"Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer","volume":"466","author":"Boonyaratanakornkit","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbrc.2020.09.058","article-title":"Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor","volume":"533","author":"Enfield","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2023.106440_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2022.108998","article-title":"Differential off-target glucocorticoid activity of progestins used in endocrine therapy","volume":"182","author":"Komane","year":"2022","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2023.106440_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2022.11.077","article-title":"The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor","volume":"639","author":"Cartwright","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2023.106440_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2022.109094","article-title":"Progestogens exhibit progestogen-, promoter- and isoform-specific effects via the progesterone receptor","volume":"187","author":"Enfield","year":"2022","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2023.106440_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106348","article-title":"Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor","volume":"232","author":"Cartwright","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2017.07.063","article-title":"Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy","volume":"491","author":"Louw-du Toit","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2023.106440_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2013.02.086","article-title":"Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy","volume":"433","author":"Africander","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2023.106440_bib23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jsbmb.2014.05.007","article-title":"A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)","volume":"143","author":"Africander","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-12-0194","article-title":"P42\/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth","volume":"20","author":"Tkach","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/me.2004-0252","article-title":"Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells","volume":"19","author":"Wu","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/me.2004-0306","article-title":"Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases","volume":"19","author":"Skildum","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/me.2006-0304","article-title":"Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways","volume":"21","author":"Carnevale","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.steroids.2005.02.012","article-title":"Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators","volume":"70","author":"Faivre","year":"2005","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2023.106440_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2006.09.030","article-title":"Progesterone signaling in breast and endometrium","volume":"102","author":"Ballar\u00e9","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/MCB.01539-06","article-title":"Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1\/2 mitogen-activated protein kinase in breast cancer cells","volume":"27","author":"Faivre","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.gene.2016.06.044","article-title":"Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: the role of membrane progesterone receptors","volume":"592","author":"Salazar","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.jsbmb.2023.106440_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/15216540600957438","article-title":"ERK1\/2 MAP kinases in cell survival and apoptosis","volume":"58","author":"Lu","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jsbmb.2023.106440_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073847","article-title":"Metastasis and MAPK Pathways","volume":"23","author":"Kciuk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2023.106440_bib35","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis (Review)","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jsbmb.2023.106440_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1947601911400901","article-title":"C-Jun N-terminal kinase 2 regulates multiple receptor tyrosine kinase pathways in mouse mammary tumor growth and metastasis","volume":"2","author":"Nasrazadani","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jsbmb.2019.02.010","article-title":"Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms","volume":"189","author":"Skosana","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.959396","article-title":"Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha","volume":"13","author":"Perkins","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib39","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1289\/ehp.95103844","article-title":"The E-screen assay: a comparison of different MCF7 cell stocks","volume":"103","author":"Villalobos","year":"1995","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jsbmb.2023.106440_bib40","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jsbmb.2023.106440_bib41","doi-asserted-by":"crossref","first-page":"31136","DOI":"10.1074\/jbc.M114.587311","article-title":"Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner","volume":"289","author":"Louw-du Toit","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2023.106440_bib42","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","article-title":"Predic Ki67 is a promising molecular target in the diagnosis of cancer (Review)","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jsbmb.2023.106440_bib43","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1200\/JCO.2005.05.064","article-title":"Cyclin D1 in breast cancer pathogenesis","volume":"23","author":"Arnold","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib44","doi-asserted-by":"crossref","first-page":"T49","DOI":"10.1530\/JME-20-0104","article-title":"Progesterone and progesterone receptors in breast cancer: past, present, future","volume":"65","author":"Horwitz","year":"2020","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jsbmb.2005.06.032","article-title":"Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells","volume":"97","author":"Bray","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mce.2011.09.016","article-title":"Progesterone receptors, their isoforms and progesterone regulated transcription","volume":"357","author":"Jacobsen","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081860","article-title":"High levels of progesterone receptor B in MCF-7 cells enable radical anti-tumoral and anti-estrogenic effect of progestin","volume":"10","author":"Bajalovic","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jsbmb.2023.106440_bib48","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1210\/me.2010-0289","article-title":"Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer","volume":"24","author":"Kobayashi","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature04872","article-title":"New signals from the invasive front","volume":"441","author":"Christofori","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2023.106440_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-019-0092-3","article-title":"Engineered models to parse apart the metastatic cascade","author":"Hapach","year":"2019","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bph.12432","article-title":"JNK signalling in cancer: In need of new, smarter therapeutic targets","volume":"171","author":"Bubici","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-65250-3","article-title":"Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer","volume":"10","author":"Gagliardi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2023.106440_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3587","article-title":"Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy","volume":"15","author":"D\u00edaz Flaqu\u00e9","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jsbmb.2023.106440_bib54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1677\/erc.0.0070143","article-title":"c- Myc in breast cancer","volume":"7","author":"Liao","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib55","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1158\/0008-5472.CAN-11-3290","article-title":"Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1\/MYC promoters","volume":"72","author":"Giulianelli","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2023.106440_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2003.09.019","article-title":"Differential effects of progestogens on breast cancer cell lines","volume":"46","author":"Franke","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2023.106440_bib57","doi-asserted-by":"crossref","unstructured":"M. Saitoh, M. Ohmichi, K. Takahashi, J. Kawagoe, T. Ohta, M. Doshida, Medroxyprogesterone acetate induces cell proliferation through up-regulation of Cyclin D1 expression via phosphatidylinositol 3-kinase \/ Akt \/ Nuclear Factor- kB cascade in human breast cancer cells, 146 (2005) 4917\u20134925. https:\/\/doi.org\/10.1210\/en.2004\u20131535.","DOI":"10.1210\/en.2004-1535"},{"key":"10.1016\/j.jsbmb.2023.106440_bib58","first-page":"6539","article-title":"Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation","volume":"52","author":"Jeng","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2023.106440_bib59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0960-0760(95)00215-4","article-title":"Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines","volume":"55","author":"Schoonen","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0960-0760(94)90170-8","article-title":"Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells","volume":"50","author":"Botella","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(99)00109-4","article-title":"Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells","volume":"154","author":"Bentel","year":"1999","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01806528","article-title":"Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells","volume":"13","author":"Poulin","year":"1989","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2023.106440_bib63","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1158\/0008-5472.CAN-07-1103","article-title":"Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics","volume":"67","author":"Liang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2023.106440_bib64","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/gme.0b013e3181d3dd0c","article-title":"Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice","volume":"17","author":"Liang","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2023.106440_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc.2016.116","article-title":"Deciphering the divergent roles of progestogens in breast cancer","volume":"17","author":"Carroll","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105548","article-title":"Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor","volume":"199","author":"Moore","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib67","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1096\/fj.06-7518com","article-title":"Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer","volume":"21","author":"Birrell","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2023.106440_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107789","article-title":"Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception","volume":"222","author":"Bick","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2023.106440_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102486","article-title":"Estetrol combined to progestogen for menopause or contraception indication is neutral on breast cancer","volume":"13","author":"Gallez","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2023.106440_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.202114314","article-title":"Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation","volume":"13","author":"Shamseddin","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jsbmb.2023.106440_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10549-005-7726-6","article-title":"Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75","volume":"94","author":"Carvajal","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2023.106440_bib72","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsbmb.2018.06.015","article-title":"Molecular mechanisms underlying progesterone-induced cytoplasmic retention of p27 in breast cancer cells","volume":"183","author":"Wang","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30898-0","article-title":"Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor","volume":"13","author":"Scabia","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jsbmb.2023.106440_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2355-5","article-title":"Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2\/M by repressing G2\/M genes","volume":"16","author":"Clare","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib75","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1530\/JME-18-0094","article-title":"Hormone therapy and breast cancer: Emerging steroid receptor mechanisms","volume":"61","author":"Perkins","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib77","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41374-021-00594-6","article-title":"Crosstalk between progesterone receptor membrane component 1 and estrogen receptor \u03b1 promotes breast cancer cell proliferation","volume":"101","author":"Pedroza","year":"2021","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jsbmb.2023.106440_bib78","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41416-020-0992-6","article-title":"Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR\/PI3K\/AKT signalling","volume":"123","author":"Pedroza","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib79","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2407-8-166","article-title":"Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion","volume":"8","author":"Fu","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002790","article-title":"Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton","volume":"3","author":"Fu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2023.106440_bib81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/ERC-09-0258","article-title":"Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase","volume":"17","author":"Fu","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1414-431x20175612","article-title":"Estrogen and progesterone promote breast cancer cell proliferation by inducing cyclin G1 expression","volume":"51","author":"Tian","year":"2018","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jsbmb.2023.106440_bib83","first-page":"1","article-title":"Studying Map Kinase Signaling With a Small-Molecule","author":"Allard","year":"2008","journal-title":"Cell Notes"},{"key":"10.1016\/j.jsbmb.2023.106440_bib84","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1073\/pnas.251194298","article-title":"SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase","volume":"98","author":"Bennett","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2023.106440_bib85","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/emboj\/17.7.2008","article-title":"Activation of the Src\/p21ras\/Erk pathway by progesterone receptor via cross-talk with estrogen receptor","volume":"17","author":"Migliaccio","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2023.106440_bib86","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/MCB.23.6.1994-2008.2003","article-title":"Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src\/Erk pathway in mammalian cells","volume":"23","author":"Ballare","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2023.106440_bib87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(01)00304-5","article-title":"Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases","volume":"8","author":"Boonyaratanakornkit","year":"2001","journal-title":"Mol. Cell."},{"key":"10.1016\/j.jsbmb.2023.106440_bib88","doi-asserted-by":"crossref","unstructured":"M.S. Islam, S. Afrin, S.I. Jones, J. Segars, Selective Progesterone Receptor Modulators - Mechanisms and Therapeutic Utility, 2020. https:\/\/doi.org\/10.1210\/endrev\/bnaa012.","DOI":"10.1210\/endrev\/bnaa012"},{"key":"10.1016\/j.jsbmb.2023.106440_bib89","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neo.2020.07.002","article-title":"A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro and tumor growth in vivo","volume":"22","author":"Zhao","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.jsbmb.2023.106440_bib90","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12672-012-0106-x","article-title":"Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors","volume":"3","author":"Dressing","year":"2012","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.jsbmb.2023.106440_bib91","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/en.2006-0974","article-title":"Steroid and G protein binding characteristics of the seatrout and human progestin membrane receptor \u03b1 subtypes and their evolutionary origins","volume":"148","author":"Thomas","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2023.106440_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cells11111785","article-title":"Membrane progesterone receptors (mPRs, PAQRs): review of structural and signaling characteristics","volume":"11","author":"Thomas","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jsbmb.2023.106440_bib93","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12964-022-00926-z","article-title":"CCM signaling complex (CSC) couples both classic and non-classic progesterone receptor signaling","volume":"20","author":"Abou-Fadel","year":"2022","journal-title":"Cell Commun. Signal."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076023001966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076023001966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:11:51Z","timestamp":1760746311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076023001966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":93,"alternative-id":["S0960076023001966"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2023.106440","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestins and breast cancer hallmarks: The role of the ERK1\/2 and JNK pathways in estrogen receptor positive breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2023.106440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106440"}}